Increased incidence of hypotension, hyperkalaemia & changes in renal function w/ angiotensin receptor blocker. May have increased hypotensive action w/ other antihypertensives. May increase risk of hypotension w/ hypotension-inducing products (eg, TCAs, antipsychotics, baclofene & amifostine). Decreased exposure w/ CYP2C9 inhibitor eg, fluconazole. Reduced plasma conc w/ rifampicine. May increase serum K w/ drugs which retain K (eg, K-sparing diuretics, amiloride, triamterene, spironolactone, K supplements or salt substitutes containing K) or K levels w/ heparin. May reversibly increase serum lithium conc & toxicity. May attenuate antihypertensive effect w/ NSAIDs (ie, selective COX-2 inhibitors, ASA & non-selective NSAIDs). May increase risk of renal function worsening w/ diuretics & NSAIDs.